Sapropterin dihydrochloride
500 mg/1 · Powder for Solution
By Camber Pharmaceuticals, Inc.
- NDC
- 31722-048
- Route
- Oral
- Therapeutic class
- Breast Cancer Resistance Protein Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Phenylalanine Hydroxylase Activator , Phenylalanine Hydroxylase Activators [MoA]
- Marketing category
- ANDA
Package sizes
- 1 PACKET in 1 CARTON (31722-048-31) / 1 POWDER, FOR SOLUTION in 1 PACKET (31722-048-01)NDC 31722-048-31Available to order
- 30 PACKET in 1 CARTON (31722-048-30) / 1 POWDER, FOR SOLUTION in 1 PACKET (31722-048-01)NDC 31722-048-30Available to order
Additional information
Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.
Request this medication
Send a request and we'll respond with availability, lot details, and pricing within 2 business hours.
Related in Oncology & Specialty
See all →Verzenio (abemaciclib)
50 mg/1 · Tablet
Eli Lilly and Company
Available to source
Verzenio (abemaciclib)
200 mg/1 · Tablet
Eli Lilly and Company
Available to source
Verzenio (abemaciclib)
100 mg/1 · Tablet
Eli Lilly and Company
Available to source
Verzenio (abemaciclib)
150 mg/1 · Tablet
Eli Lilly and Company
Available to source
